Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Loss Per Share

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A common stock is as follows:



	Twelve months ended Dec. 31,
(in thousands, except per share amounts)	2025		2024		2023
Numerator:
Net loss	$	(497,755)	$	(7,319)	$	(151,270)
Less: Net loss attributable to non-controlling interests	(240,629)		(4,391)		(88,013)
Net loss attributable to GoHealth, Inc.	(257,126)		(2,928)		(63,257)
Less: Dividends paid on redeemable convertible preferred stock	3,924		3,661		3,566
Net loss attributable to common stockholders	(261,050)		(6,589)		(66,823)
Denominator:
Weighted-average shares of Class A common stock outstanding—basic and diluted	12,940		9,980		9,292
Net loss per share of Class A common stock—basic and diluted	$	(20.17)	$	(0.66)	$	(7.19)

Schedule of Antidilutive Securities Excluded From Calculation of Diluted Income (Loss) Per Share

The following number of shares were excluded from the calculation of diluted income (loss) per share of Class A common stock because the effect of including such potentially dilutive shares would have been antidilutive:


	Dec. 31,
(in thousands)	2025	2024	2023
Equity awards	3,296	2,488	1,973
Redeemable convertible preferred stock	4,113	3,989	3,873
Class B common stock	12,621	12,711	12,814